Molina Healthcare (NYSE:MOH) Given New $412.00 Price Target at TD Cowen

Molina Healthcare (NYSE:MOH) had its price objective cut by TD Cowen from $453.00 to $412.00 in a report released on Tuesday, Benzinga reports. They currently have a buy rating on the stock.

MOH has been the topic of a number of other research reports. Bank of America lowered Molina Healthcare from a neutral rating to an underperform rating and set a $439.00 price target on the stock. in a research report on Thursday, March 28th. StockNews.com lowered Molina Healthcare from a strong-buy rating to a buy rating in a research report on Thursday, February 8th. Wells Fargo & Company reduced their price target on Molina Healthcare from $410.00 to $375.00 and set an equal weight rating on the stock in a research report on Monday. Stephens reiterated an equal weight rating and issued a $390.00 price target on shares of Molina Healthcare in a research report on Thursday, April 25th. Finally, Cantor Fitzgerald reiterated an overweight rating and issued a $406.00 price target on shares of Molina Healthcare in a research report on Thursday, April 4th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of Hold and a consensus target price of $398.55.

Molina Healthcare Trading Down 0.5 %

Shares of MOH stock opened at $342.10 on Tuesday. The firm has a market capitalization of $20.05 billion, a P/E ratio of 18.56, a P/E/G ratio of 0.96 and a beta of 0.47. Molina Healthcare has a twelve month low of $266.35 and a twelve month high of $423.92. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.53. The stock’s fifty day simple moving average is $387.99 and its 200 day simple moving average is $372.33.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Wednesday, April 24th. The company reported $5.73 earnings per share for the quarter, topping analysts’ consensus estimates of $5.46 by $0.27. The business had revenue of $9.93 billion for the quarter, compared to analyst estimates of $9.45 billion. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. Molina Healthcare’s quarterly revenue was up 21.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $5.81 EPS. As a group, sell-side analysts predict that Molina Healthcare will post 23.62 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Richard M. Schapiro sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total transaction of $401,050.00. Following the transaction, the director now directly owns 11,207 shares of the company’s stock, valued at approximately $4,494,567.35. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, Director Richard M. Schapiro sold 711 shares of the company’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $384.06, for a total transaction of $273,066.66. Following the transaction, the director now directly owns 12,207 shares of the company’s stock, valued at approximately $4,688,220.42. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Richard M. Schapiro sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total value of $401,050.00. Following the transaction, the director now directly owns 11,207 shares in the company, valued at $4,494,567.35. The disclosure for this sale can be found here. In the last three months, insiders have sold 16,711 shares of company stock valued at $6,472,517. 1.11% of the stock is owned by company insiders.

Institutional Trading of Molina Healthcare

Several institutional investors and hedge funds have recently modified their holdings of MOH. Annis Gardner Whiting Capital Advisors LLC purchased a new stake in shares of Molina Healthcare in the third quarter worth approximately $30,000. McIlrath & Eck LLC purchased a new stake in shares of Molina Healthcare in the fourth quarter worth approximately $34,000. VisionPoint Advisory Group LLC raised its stake in shares of Molina Healthcare by 105.6% in the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock worth $36,000 after purchasing an additional 57 shares during the last quarter. Raleigh Capital Management Inc. raised its stake in shares of Molina Healthcare by 40.4% in the third quarter. Raleigh Capital Management Inc. now owns 125 shares of the company’s stock worth $41,000 after purchasing an additional 36 shares during the last quarter. Finally, Principal Securities Inc. purchased a new stake in shares of Molina Healthcare in the fourth quarter worth approximately $42,000. 98.50% of the stock is owned by hedge funds and other institutional investors.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.